Resistant recurrent aphthous stomatitis in an AIDS patient-Efficacy and problems of long-term corticosteroid therapy-:-Efficacy and problems of long-term corticosteroid therapy-
スポンサーリンク
概要
- 論文の詳細を見る
Recurrent aphthous stomatitis (RAS) in HIV patients is treated by local application of corticosteroid or oral administration of 40-60 mg/day of prednisone or prednisolone for less than 14 days, as recommended by treatment guidelines. However, when the immune system does not improve, large aphthous stomatitis keeps recurring over a short period of time. We treated an AIDS patient with resistant RAS using long-term prednisolone therapy.<BR>The patient presented with hemophilia B complicated by AIDS. Aphthous stomatitis lesions were 10-15 mm in diameter. Aphthous stomatitis was unresponsive to corticosteroid ointment, but responded to oral administration of prednisolone 40 mg/day for 4-7 days. However, when the immune system became severely compromised, aphthous stomatitis kept recurring over a short period of time.<BR>As a result, 5 mg of prednisolone was administered every other day, and this was successful in suppressing recurrence without adverse effects.<BR>Long-term prednisolone therapy was useful in treating RAS when the immune system was severely compromised. In such treatment, close communication and teamwork is required between the physician and dentist to prevent adverse effects.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果